Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237872 · ClinicalTrials.gov registry record
Detection of Brown Adipose Tissue by Magnetic Resonance Imaging
A clinical trial of Obesity and Brown Adipose Tissue, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 8
- Enrollment target
- 2
- Study locations
NCT02237872 is a study of Obesity and Brown Adipose Tissue that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 8 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02237872, a study of Obesity and Brown Adipose Tissue, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary goal of this study is to assess the accuracy of conventional fat fraction proton MRI for the detection of Brown Adipose Tissue (BAT) in healthy subjects using \[18F\]-2-fluoro-2-deoxy-D-glucose (fluorodeoxyglucose) -PET as gold standard. In this pilot study, MRI and PET imaging of BAT of healthy adult volunteers will be performed on a combined PET/MRI scanner under mild cold condition.
Conditions Studied
Study Locations (2)
North Carolina
- Biomedical Research Imaging Center - Chapel Hill
- Biomedical Research Imaging Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-01-20 |
| Est. Completion | 2015-08-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02237872
The ClinicalTrials.gov registry entry for NCT02237872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT02237872 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02237872 about?
NCT02237872 is a clinical study titled "Detection of Brown Adipose Tissue by Magnetic Resonance Imaging". The primary goal of this study is to assess the accuracy of conventional fat fraction proton MRI for the detection of Brown Adipose Tissue (BAT) in healthy subjects using \[18F\]-2-fluoro-2-deoxy-D-glucose (fluorodeoxyglucose) -PET as gold standard. In this pilot study, MRI and PET imaging of BAT o...
What is the current status of trial NCT02237872?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2015-01-20. Estimated completion is 2015-08-27.
What conditions does trial NCT02237872 study?
This clinical trial studies the following conditions: Obesity, Brown Adipose Tissue.
Who is sponsoring clinical trial NCT02237872?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02237872 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.